Chess grandmasters live longer—just like elite athletes

Viswanathan Anand, Chess Grandmaster. Image credit: Artsfon
Viswanathan Anand, Chess Grandmaster. Image credit: Artsfon

It’s well established that elite athletes have a longer life expectancy than the general public. A recent review of over 50 studies comprising half a million people estimated the athletic advantage to be between 4 and 8 years, on average.

One can easily imagine how the same genetic endowment and training necessary to develop physical prowess in sport might also manifest in physical health. Now for the first time, a study published in PLOS One (open access) shows that athletes of the mind – chess grandmasters – show the same longevity advantage as athletes of the body.

[B]oth groups showed a sizeable life expectancy advantage compared to the general population. For instance, in 2010, the average life expectancy of a chess grandmaster aged 25 was 6.3 years longer than the average for a 25-year-old member of the public. For a 55-year-old chess grandmaster, life expectancy was 4.5 years longer.

The study can’t tell us anything about why chess grandmasters live longer than the public. It’s possible some of the causes are indirect, such as the grandmasters possibly having higher average IQ (which is itself associated with longevity); elite chess players are also known to take more care of their physical fitness than the general population; and the social and economic benefits of becoming a grandmaster, especially notable in Eastern Europe, may have health benefits.

Read full, original post: Chess grandmasters show the same longevity advantage as elite athletes

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpoint— 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.